Blaze Bioscience is developing a real-time surgical imaging system that highlights tozuleristide localized to breast cancer lesions during breast-conserving cancer resection surgery.
In this webinar from optics.org, the panelists discuss with QUEL how custom optical tissue phantoms and benchmarking tools were critical in:
The result - Blaze Biosciences was able to get a product through to clinical trials faster than ever before.
Watch now and learn how Blaze and QUEL's partnership delivered an impactful medical device to the clinic.
Steven Daly, CEO, Blaze Bioscience
David Kittle, PhD, DK Biophotonics
Alberto Ruiz, PhD, CTO, QUEL Imaging
Moderated by Ethan LaRochelle, PhD, CEO, QUEL Imaging
QUEL Imaging partners with product development teams at all phases for development to launch reliable, high performance medical devices into clinical practice.
Our team can help you by:
Reach out today to learn how QUEL Imaging can help your team accelerate their product development.